4-chloro-1-methyl-N-[(E)-4-methylpentan-2-ylideneamino]-5-(trifluoromethyl)pyrazole-3-carboxamide
C12H16ClF3N4O — CID 40609521
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-chloro-1-methyl-N-[(E)-4-methylpentan-2-ylideneamino]-5-(trifluoromethyl)pyrazole-3-carboxamide
4-chloro-1-methyl-N-[(E)-4-methylpentan-2-ylideneamino]-5-(trifluoromethyl)pyrazole-3-carboxamide (PubChem CID 40609521) has the molecular formula C12H16ClF3N4O and a molecular weight of 324.73 g/mol. Its IUPAC name is 4-chloro-1-methyl-N-[(E)-4-methylpentan-2-ylideneamino]-5-(trifluoromethyl)pyrazole-3-carboxamide.
Molecular Properties
| Compound Name | 4-chloro-1-methyl-N-[(E)-4-methylpentan-2-ylideneamino]-5-(trifluoromethyl)pyrazole-3-carboxamide |
|---|---|
| PubChem CID | 40609521 |
| Molecular Formula | C12H16ClF3N4O |
| Molecular Weight | 324.73 g/mol |
| Exact Mass | 324.10 |
| IUPAC Name | 4-chloro-1-methyl-N-[(E)-4-methylpentan-2-ylideneamino]-5-(trifluoromethyl)pyrazole-3-carboxamide |
| SMILES | C/C(CC(C)C)=N\NC(=O)c1nn(C)c(C(F)(F)F)c1Cl |
| InChI | InChI=1S/C12H16ClF3N4O/c1-6(2)5-7(3)17-18-11(21)9-8(13)10(12(14,15)16)20(4)19-9/h6H,5H2,1-4H3,(H,18,21)/b17-7+ |
| InChIKey | LWUIPCHJYHMVJW-REZTVBANSA-N |
| XLogP | 3.24 |
| TPSA | 59.28 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 4 |
| Rotatable Bonds | 4 |
| Heavy Atoms | 21 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 324.73 |
| LogP ≤ 5 | 3.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 4 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'imine_1', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 40609521 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.